Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06354517

The Impact of the SENSE Program on NICU

The Impact of the SENSE Program on Parent and Newborn

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Yuksek Ihtisas University · Academic / Other
Sex
All
Age
24 Weeks – 42 Weeks
Healthy volunteers
Not accepted

Summary

The SENSE program will be applied to babies receiving treatment in the neonatal intensive care unit and the effect of the application on the baby and parents will be examined.

Detailed description

For the growth and health of the baby, the intrauterine environment provides the fetus with protective physical barriers and sensory exposures timed appropriately for its development. These early exposures occur during sensory development in the intrauterine environment, and there are differences in the timing of development of each sense. When the baby is born prematurely, the intrauterine environment is replaced by the Neonatal Intensive Care Unit environment. The sensory environment of the preterm baby includes the experiences of touch, movement, smell, sound, light, frequent nociceptive pain and disruption of sleep. The mismatch between the infant's underdeveloped coping skills and the stimulating NICU environment can cause physiological imbalance, negatively impact growth and development, and ultimately predispose to the development of long-term neurodevelopmental consequences. Although harmful sensory exposures can negatively affect the development of the preterm baby, appropriate positive sensory exposures positively affect brain development.

Conditions

Interventions

TypeNameDescription
OTHERSENSE groupParents of babies in this group will be given SENSE program training. After the training, parents will care for their babies within the scope of the SENSE program. These babies will receive care from their parents with positive sensory exposures within the scope of the SENSE program from admission to the clinic until discharge. Data collection forms will be administered to babies and their parents.

Timeline

Start date
2024-04-01
Primary completion
2025-05-30
Completion
2025-05-30
First posted
2024-04-09
Last updated
2024-04-09

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06354517. Inclusion in this directory is not an endorsement.